Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Use of daily low ...

A groundbreaking study recently published in JAMA indicates that aspirin may not be necessary as part of an antithrombotic regimen for patients with a fully magnetically levitated left ventricular ...

PHILADELPHIA -- Dropping aspirin from the antithrombotic regimen after HeartMate 3 left ventricular assist device (LVAD) implantation appeared safer than the usual combination approach in the ...

What We're Reading, October 22, 2015: can aspirin prevent the recurrence of cancer, Clinton wants careful scrutiny of insurance mergers, and small businesses race against time to comply with the ACA.

India faces a rapidly escalating triple syndemic of obesity, type 2 diabetes (T2D), and atherogenic dyslipidemia, conditions ...

The US Preventive Services Task Force (USPSTF) has backtracked on low-dose aspirin for the prevention of colorectal cancer (CRC), stating in new guidance that the evidence is too murky to make a ...

Please provide your email address to receive an email when new articles are posted on . Daily low-dose aspirin use over 7 years did not affect the risk for incident dementia or cognitive decline in ...

(HealthDay News) — Rivaroxaban plus aspirin is superior to aspirin alone for patients with stable atherosclerotic vascular disease, according to a study published online in the New England Journal of ...

Aspirin and clonidine increased the risk of major bleeding and clinically important hypotension. Aspirin and clonidine increased the risk of major bleeding and clinically important hypotension in ...

A large study out of Scotland has shown that aspirin and antioxidant supplements are ineffective in the primary prevention of heart attacks in people with diabetes and asymptomatic arterial disease.

A low ankle-brachial index (ABI; ratio of systolic pressure at the ankle to that in the arm; normal range, 1.1–1.4) is a marker for peripheral vascular disease. Scottish investigators used ABI to ...